JMP Securities Maintains Market Outperform on Exelixis, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has maintained a Market Outperform rating on Exelixis and raised its price target from $29 to $34.
October 16, 2024 | 11:20 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities has reaffirmed its positive outlook on Exelixis by maintaining a Market Outperform rating and increasing the price target from $29 to $34.
The increase in the price target from $29 to $34 by JMP Securities suggests a positive outlook for Exelixis, likely leading to a short-term increase in stock price as investors react to the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100